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Abstract. Amultimodal mass spectrometry imaging (MSI) based approach was used
to characterize the molecular content of crystal-like structures in a frozen and paraffin
embedded piece of a formalin-fixed rabbit kidney. Matrix assisted laser desorption/
ionization time-of-flight (MALDI-TOF) imaging and desorption electrospray ionization
(DESI)mass spectrometry imaging were combined to analyze the frozen and paraffin
embedded sample without further preparation steps to remove the paraffin. The
investigated rabbit kidney was part of a study on a drug compound in development,
in which severe renal toxicity was observed in dosed rabbits. Histological examina-
tion of the kidney showed tubular degeneration with precipitation of crystal-like
structures in the cortex, which were assumed to cause the renal toxicity. The MS
imaging approachwas used to find out whether the crystal-like structures were composed of the drug compound,
metabolites, or an endogenous compound as a reaction to the drug administration. The generated MALDI-MSI
data were analyzed using principal component analysis. In combination with the MS/MS results, this way of data
processing demonstrates that the crystal structures were mainly composed of metabolites and relatively little
parent drug.
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Introduction
Mass spectrometry imaging (MSI) is an increasingly pop-ular technique providing insight into the molecular dis-
tribution inside thin tissue samples [1]. In contrast, traditional
histopathologic investigation can only visualize structural
abnormalities.
Matrix assisted laser desorption ionization mass spec-
trometry imaging (MALDI-MSI) is such a technique that is
able to record molecular images of tissue sections. Ions are
generated from the sample surface by irradiating it with a
UV laser [2, 3]. The laser moves over the sample in an
array of spots, and a spectrum is acquired from the ionized
species on every position. The information obtained from
the whole sample is reconstructed into a 2D image. The
same principle is used in desorption electrospray ionization
(DESI), where the ionization is attributed to charged
droplets that hit the sample surface spot by spot. After
dissolution of the ionized analytes, the charged droplets
travel into a mass spectrometer to be analyzed [1, 4–6].
The power of MSI over light microscopy is the ability to
identify compounds in combination with structural abnor-
malities in tissues.
Pathologists commonly embed formalin-fixed tissues
in paraffin. Formalin fixation results in the cross-linking
of proteins and paraffin embedding preserves the tissue
morphology, makes it easier to cut sections which are
large or fragile, and creates the possibility of long-term
storage. Formalin-fixed and paraffin-embedded (FFPE)
samples are ideal for microscopic investigation after con-
trast staining.
However, protein cross-linking caused by formalin fix-
ation is not favorable for MSI, since mass spectrometry
imaging is based on the mapping of molecules, including
these cross-linked proteins. Besides, formalin fixation
causes the formation of sodium adducts and paraffin
causes severe ion suppression [7]. In general, the risk ofCorrespondence to: Ron Heeren; e-mail: r.heeren@maastrichtuniversity.nl
delocalization of compounds from the tissue into the em-
bedding material is high. Several wash steps are usually
required to avoid ion suppression and the formation of
sodium adducts, with an associated risk of delocalization
and washing away analytes causing a lower concentration
as a result.
It is essential not to alter the morphology and com-
position of the biological tissue prior to analysis of
biological tissue samples using mass spectrometry imag-
ing [7, 8]. This ensures that the best sensitivity, accura-
cy, and reproducibility can be obtained [7, 9]. It appears
that freezing of a tissue by free-floating in liquid nitro-
gen after sampling from an organism gives the best
preservation. Sometimes dry-ice chilled isopentane or
hexane is used for larger samples to prevent fracturing
[9–11].
In this study, we show the combination of MALDI and
DESI mass spectrometry imaging to detect, map, and identify
a drug molecule and its major metabolites in a formalin-fixed
(FF) frozen kidney sample with a formalin-fixed paraffin-em-
bedded (FFPE) kidney sample. Principal component analysis
(PCA) of the MALDI-MSI data was used as a tool to give
insight into the contribution of different molecules to the renal
crystal structures.
A c-Met tyrosine kinase inhibitor in development was
administered by oral gavage to male rabbits for 1 month as
part of toxologic research and the drug’s potential as an anti-
cancer drug (Figure 1c) [12]. Renal toxicity was observed in
the dosed rabbits in a similar way as described in reference
[13]. The kidney weights were increased and kidneys
showed pale discoloration or discolored foci at necropsy.
Histopathological examination of kidneys showed degener-
ative changes composed of dilatation of collecting ducts and
cortical tubules, multifocal vacuolization, and tubular hy-
pertrophy. Within the lumen of these tubules, birefringent
(in polarized light) granular or crystalline material was
observed (Figure 1a, b). To test whether the drug compound
or one or several of its metabolites caused this structure
formation, MSI was considered to be a suitable technique
to reveal their molecular content [14].
Less interference from either paraffin itself or cross-linked
species was expected in paraffin-embedded tissue from this
study on a low molecular drug compound than for a study on
high mass molecules. By evaluating the MALDI-MSI and
DESI-MSI feasibility and performance on tissue slides pre-
pared and stored within formalin, but also embedded in paraf-
fin, as is typically done in toxicity studies, would enable a
combined analysis of the same tissue samples with light mi-
croscopy and MSI [15, 16].
Experimental
Tissue Sectioning
Half a formalin-fixed kidney from a 1-month repeated
dose oral toxicity study in male rabbits with the drug
compound in development was obtained from Janssen
R&D (Beerse, Belgium). The specimen was frozen at –
20°C overnight. Sections of 20 and 30 μm thickness
were cut using a cryo-microtome (HM525; MICROM
Walldorf, Germany and CM3050 S; Leica, Wetzlar,
Germany, respectively) and thaw mounted on Superfrost
microscope glass slides (Thermo Scientific, Waltham,
Massachusetts USA).
The other half of the formalin-fixed kidney de-
scribed above was provided embedded in paraffin
(FFPE) by Janssen R&D (Beerse, Belgium); 8 and
10 μm thick sect ions were cut us ing a cryo-
microtome (CM3050 S; Leica) and mounted on
Superfrost microscope glass slides (Thermo Scientific).
MALDI Imaging
The slides with frozen tissue sections were dried in a
vacuum desiccator for at least 15 min before matrix depo-
sition. A solution of 20 mg/mL of 2,5-dihydroxybenzoic
acid (DHB) in 1:1 acetonitrile (ACN):0.1% 2,2,2-
trifluoroethanoic acid (TFA) in H2O was prepared and
deposited in 40 spray cycles on all glass slides using a
SunCollect MALDI-spotter (SunChrom, Friedrichdorf
Germany). In the first cycle, a flow rate of 5 μL/min was
used, in the second 10 μL/min, in the third 15 μL/min, and
30 μL/min for the remaining cycles.
The 20 μm frozen kidney and 10 μm FFPE tissue samples
were analyzed on a SYNAPT G1 HDMS Q-ToF instrument
with a MALDI ionization source equipped with a 200 Hz
Nd:YAG laser (355 nm) (Waters Corporation, Milford, MA,
USA). The system was running in positive ionization mode
with 10,000 mass resolution at m/z 556 in V-ToF mode and
analyzing m/z 50–500. Images were acquired with a sample
stage step size of 150 μm.
The raw data were converted with a m/z bin size of 0.1
to a suitable format for BioMap (Novartis, Basel,
Switzerland). The ion images and their overlays with the
optical scan images of the tissue sections were generated
with the same software.
Multivariate analysis was performed with the in-
house written ChemomeTricks toolbox for MATLAB
(ver. 7.0, The MathWorks) to determine the composition
of the crystal-like structures. Principal component anal-
ysis (PCA) was employed to find sets of correlated
mass channels that represent the maximum amount of
variance.
Prior to the MS/MS imaging analysis, 1 μL of 500 μM
of the drug compound in 1:1 ACN:H2O mixed 1:1 (v/v)
with the DHB matrix solution was dry-spotted on a
MALDI target plate. Product ion spectra were generated
through the fragmentation of a precursor ion at m/z 378
(corresponding to the mass of the protonated drug mole-
cule) with a collision energy of 50 eV in the trap collision
cell of the Synapt instrument. The same 500 μM solution
in 1:1 ACN:H2O was deposited as a spot next to the
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formalin-fixed frozen kidney tissue section before matrix
deposition. An area including this spotted standard was
selected to perform an MS/MS imaging experiment with
fragmentation of m/z 380, related to the major metabolite
of the drug compound. BioMap software was also used
here to generate overlay images and correlate the frag-
ments observed in the tissue with the ones in the spotted
standard.
DESI Imaging
A 30 μm frozen kidney tissue section and an 8 μm
FFPE tissue section were analyzed on a Q Exactive
Hybrid Quadrupole-Orbi t rap mass spect rometer
(Thermo Scientific, Bremen, Germany), operating in
positive ionization mode and detecting the m/z 350–
500 mass range. A mass resolution of 70,000 (at m/z
200) was chosen for the frozen tissue section, and a
resolution of 140,000 (at m/z 200) for the paraffin
embedded section to obtain more selectivity.
An Acquity pump (Waters, Milford, MA, USA) set at
800 μL/min flow rate was used to generate a DESI spray.
A homemade flow splitter was used to reduce the flow rate
to 2.5 μL/min at the DESI emitter, which was a 50 μm
fused silica capillary (Prosolia, Indianapolis, IN, USA) on
a 3.5 kV high voltage with 7.6 bar nitrogen gas pressure.
The distance between the emitter and the sample was
~3 mm and the emitter and the MS inlet were separated
by ~10 mm. The distance between the MS inlet and the
sample was kept as small as possible. Chloroform, aceto-
nitrile and formic acid (1:1:0.1v%) were used as spraying
solvent.
DESI images were generated using a surface scan rate
of 100 μm/s (1 s/scan at 70,000 resolution and 2
microscans) for the formalin-fixed frozen tissue section
and 130 μm/s (0.77 s/scan at 140,000 resolution and 1
microscan) for the formalin-fixed paraffin-embedded sec-
tion. This resulted in tissue section images with a
100 μm pixel size. The DESI images were mapped
using the BioMap software (Novartis) as described
above.
Results and Discussion
MALDI and DESI imaging experiments were per-
formed on a frozen and a paraffin-embedded part of a
formalin-fixed kidney to explore the possibility of
analysis on typically prepared samples for histology.
Figure 1. (a) Histology of a hematoxylin and eosin stained section from a formalin-fixed paraffin-embedded kidney of a dosed
rabbit. The arrows point out the cortical intratubular crystalline material. The insert (b) is an overview of the kidney. (c) Chemical
structure of the drug compound in the pipeline
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We show the potential of this approach with the re-
search into crystal-like structures found in rabbit kid-
neys and whether they could be directly linked to the
drug compound or its metabolites that was administered
to the animals.
The spatial distribution of molecular compounds in
the FF frozen tissue section of a kidney obtained from
a dosed rabbit was directly visualized using BioMap
software. The drug compound has a 12C monoisotopic
mass of 377 Da and was expected to show up in the
protonated form at m/z 378. The m/z 380 peak corre-
sponds to the protonated molecule of the metabolite
originating from demethylation of the tertiary amine
on the imidazole ring resulting in a secondary amine
with a proton instead of a methyl group [(–15 + 1)= –
14 Da] and oxidation of the quinoline ring (+16 Da)
from the parent drug. The peak at m/z 394 was linked
to a protonated molecule of the metabolite. These
masses were plotted as overlays of the molecular dis-
tribution with the optical image of the tissue section in
Figure 2 for both MALDI (a) and DESI (b) imaging
experiments.
At first sight, the pixels with the highest intensities
for the m/z values corresponding to the drug compound
and two metabolites seem to be present on the same
location and in the shape of dots (Figure 2). They
appear mainly in the cortex where the crystals were
found during histopathologic investigation (Figure 1)
[12].
In order to identify the compounds that jointly consti-
tute the crystal-like structures in the cortex of the kidney,
principal component analysis (PCA) was performed on
the MALDI-MSI data. PCA is a multivariate type of
analysis that is widely used to reduce the size of mass
spectrometry imaging data sets by describing variables
with more relevant principal components. By using this
approach, correlation between variables can be revealed,
as well as correlations between samples [17, 18].
Figure 3c represents the loading plot of principal com-
ponent number 4. The selection of this principal compo-
nent was based on the presence of a high abundant m/z
380 peak, which corresponds to the demethylated and
Figure 3. Images describing the positive (a) and negative (b)
part of principal component 4 of a frozen formalin-fixed kidney
tissue section and their corresponding loading plots (c). The
most abundant metabolite (m/z 380) and also known metabo-
lites with m/z values of 394 and 364 are circled
Figure 2. MALDI and DESI image overlays representing the
spatial distribution of the drug compound (m/z 378) and its most
abundant metabolites (m/z 380 and 394) in a tissue section of a
formalin-fixed frozen rabbit kidney
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oxidized metabolite of the drug compound. Besides m/z
380, also m/z 364 (demethylation), m/z 394 (oxidation),
and m/z 410 (double oxidation) contribute to the positive
part of PC 4 and are circled in red. By means of these
plots, distribution images were reconstructed as shown in
(a) and (b), were a is the positive part of the plot
representing the crystal pattern, and b the negative part,
respectively.
The PCA on the MALDI-MSI data confirms the observa-
tion that the metabolites mainly precipitate in the cortex of the
kidney. The positive part of the principal component appears
again as a dotted pattern in the cortex of the kidney tissue
(Figure 3).
The same experiment as described above was per-
formed using the FFPE sample. The overlayed ion im-
ages of m/z 378, m/z 380 and m/z 394 obtained by
MALDI (a) and DESI (b) MSI are represented in
Figure 4. The peaks at m/z 378 and 380 appear in a
similar pattern as in the frozen tissue sample, though ion
intensity for the parent drug (m/z 378) is much lower.
Also, the metabolite at m/z 394 could not be detected
with MALDI-MSI under the current conditions. These
intensity losses and differences in intensities of the me-
tabolites can be due to washing out the compounds of
interest during FFPE sample preparation, ion suppression
during the ionisation process, or both.
PCA was also performed on this MALDI-MSI data set,
and for this sample, the fifth PC was selected. The loading
plots (c) and correlating reconstructed images of the posi-
tive and negative side of PC 5 (a) and (b) are shown in
Figure 5. The m/z 364 (demethylation) and m/z 394
(oxidation) peaks are present in the positive part of PC 5
as well.
A MALDI-MS/MS product ion experiment was per-
formed to correlate the precursor masses found at the
location of the intratubular cortical crystal-like structures
with the standard of the drug compound. Figure 6a
shows the product ion spectrum obtained for the drug
Figure 4. MALDI and DESI image overlays representing the
spatial distribution of the drug compound (m/z 378) and its most
abundant metabolites (m/z 380 and 394) in a tissue section of a
formalin-fixed and paraffin-embedded rabbit kidney
Figure 5. MALDI images describing the positive (a) and neg-
ative (b) part of principal component 5 of a FFPE kidney tissue
section and their corresponding loading plots (c). The most
abundant metabolite (m/z 380) and also knownmetabolites with
m/z values of 394 and 364 are circled
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standard by MALDI-QTOF analysis. The major product
ions are annotated with their tentative structure. A
MALDI-MS/MS product ion imaging experiment with
m/z 380 as a precursor was performed to identify the
masses found in the crystal-like structures. Figure 6b
shows the spatial distribution of the most abundant
peaks that appear in both the spotted standard and the
tissue area. All these fragments could be correlated to
the known fragments originating from the drug com-
pound (m/z 159 and 179), or to fragments shifted by
16 Da because of oxygen addition (m/z 145, 175, 195,
and 221).
As mentioned before, the crystal-like structures were
found in the cortex of the rabbit kidneys. It became clear
from the overlays in Figure 6b that the molecular frag-
ments from the drug were mostly present in that area.
Besides, the same dotted pattern as the crystal-like struc-
tures was found in the optical images and previous ion
distribution images. The presence of the +16 Da shifted
(oxidized) fragments at m/z 145, 175, 195, and 221 indi-
cates that based on the tentative product ion structures
shown in Figure 6a, the oxidation on the metabolites con-
stituting the crystal-like structures should be located at the
quinoline moiety of the drug compound.
Conclusions
Complementary MALDI and DESI mass spectrometry
imaging measurements of the formalin-fixed and frozen
kidney samples showed that the crystal-like structures
observed in the kidney of dosed rabbits are predomi-
nantly composed of metabolites originating from de-
methylation and/or oxidation and only minor concentra-
tions of the drug compound itself.
The identification of the main metabolite peak (m/z
380) was accomplished by MALDI-MS/MS product ion
imaging, whereby fragments found in the kidney tissue
were directly related to known fragments obtained from
the drug standard. PCA confirmed that the drug com-
pound co-localizes with its demethylated and oxidized
metabolites.
In summary, we succeeded in demonstrating drug-
metabolite correlation directly in a formalin-fixed paraf-
fin-embedded tissue sample by PCA on both MALDI
and DESI imagind MS data. Both ionization methods
revealed that the abundance of the masses corresponding
to the drug compound and its main metabolite was much
lower compared with formalin-fixed frozen and non-
embedded tissue sections.
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